BCM
Burrage Capital Management Portfolio holdings
AUM
$99.7M
1-Year Return
65.92%
This Quarter Return
-23.88%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$102M
AUM Growth
-$47.6M
(-32%)
Cap. Flow
-$6.73M
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
57.94%
Holding
38
New
9
Increased
8
Reduced
13
Closed
7
Top Buys
| 1 |
Cytokinetics
CYTK
|
+$3.61M |
| 2 |
Regenxbio
RGNX
|
+$3.54M |
| 3 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
+$3.27M |
| 4 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$3.25M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$2.11M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
+$11.9M |
| 2 |
Ascendis Pharma
ASND
|
+$6.09M |
| 3 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$3.72M |
| 4 |
US Physical Therapy
USPH
|
+$2.46M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$2.29M |
Sector Composition
| 1 | Healthcare | 97.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $12.5M | 12.34% |
893,698
-71,821
| -7% | -$1.01M |
|
2
PTC Therapeutics
PTCT
$4.74B
| $8.16M | 8.03% |
181,237
-14,488
| -7% | -$652K |
|
3
OrthoPediatrics
KIDS
$500M
| $6.67M | 6.57% |
171,113
-14,505
| -8% | -$566K |
|
4
NeoGenomics
NEO
$1.01B
| $5.24M | 5.16% |
192,277
-6,071
| -3% | -$165K |
|
|
ISEE
5
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.99M | 4.91% |
1,521,382
-130,089
| -8% | -$427K |
|
6
AnaptysBio
ANAB
$658M
| $4.48M | 4.41% |
331,919
-28,181
| -8% | -$380K |
|
|
LITS
7
Lite Strategy, Inc. Common Stock
LITS
$91M
| $4.47M | 4.4% |
150,903
-5,347
| -3% | -$158K |
|
8
Y-mAbs Therapeutics
YMAB
$391M
| $4.41M | 4.34% |
171,788
-14,961
| -8% | -$384K |
|
9
Crinetics Pharmaceuticals
CRNX
$3.19B
| $4.02M | 3.96% |
282,272
+76,546
| +37% | +$1.09M |
|
|
GTHX
10
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.9M | 3.83% |
378,145
-36,263
| -9% | -$374K |
|
|
11
Cytokinetics
CYTK
$6.01B
| $3.61M | 3.56% |
+318,273
| New | +$3.61M |
|
|
12
Regenxbio
RGNX
$460M
| $3.54M | 3.48% |
+115,000
| New | +$3.54M |
|
13
CytomX Therapeutics
CTMX
$325M
| $3.46M | 3.41% |
482,982
+6,872
| +1% | +$49.3K |
|
|
TVRD
14
Tvardi Therapeutics, Inc. Common Stock
TVRD
$324M
| $3.29M | 3.24% |
7,188
-706
| -9% | -$323K |
|
|
TECX
15
Tectonic Therapeutic, Inc. Common Stock
TECX
$319M
| $3.27M | 3.22% |
+18,825
| New | +$3.27M |
|
|
TPTX
16
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $3.25M | 3.2% |
+77,172
| New | +$3.25M |
|
17
Korro Bio
KRRO
$291M
| $3.01M | 2.96% |
3,478
+2,408
| +225% | +$2.08M |
|
18
Aurinia Pharmaceuticals
AUPH
$1.69B
| $2.9M | 2.86% |
196,438
+69,905
| +55% | +$1.03M |
|
|
TCDA
19
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.78M | 2.74% |
131,661
+61,008
| +86% | +$1.29M |
|
|
20
Xenon Pharmaceuticals
XENE
$2.77B
| $2.11M | 2.08% |
+200,000
| New | +$2.11M |
|
21
Apellis Pharmaceuticals
APLS
$3.07B
| $2.04M | 2.01% |
74,452
-775
| -1% | -$21.2K |
|
|
ZGNX
22
DELISTED
Zogenix, Inc.
ZGNX
| $1.65M | 1.63% |
+70,000
| New | +$1.65M |
|
|
AIMT
23
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $1.61M | 1.58% |
+112,546
| New | +$1.61M |
|
24
Adverum Biotechnologies
ADVM
$64.2M
| $1.56M | 1.53% |
15,601
+12,421
| +391% | +$1.24M |
|
|
AERI
25
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.19M | 1.17% |
88,445
-99,531
| -53% | -$1.33M |
|